Tirzepatide, also known as LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes. This innovative peptide demonstrates superior efficacy in glucose control and weight loss compared to other treatments like Dulaglutide.
With a molecular formula of C225H348N48O68, tirzepatide appears as a white powder and is supplied in vials for research purposes. Its unique structure includes a PEG modification on the lys side chain, enhancing water solubility and functionality. Tirzepatide costco offers a high-affinity binding profile, favoring GIP receptors over GLP-1 receptors, which contributes to its enhanced hyperglycemia reduction capabilities.
Clinical trials, such as SURMOUNT-1, have shown significant weight loss results with tirzepatide, averaging 15% to 20.9% over 72 weeks depending on dosage. It has received FDA Fast Track designation for obesity treatment, highlighting its potential in managing weight-related health conditions.
For research applications, tirzepatide costco is an ideal choice due to its high purity and consistent quality. It is important to store the peptide in a cold, dry, dark place to maintain stability, avoiding repeated freezing and thawing, overexposure to air, and light. Proper storage ensures the integrity of the peptide for experimental use.
This product is intended for research purposes only and not for personal use. Researchers can rely on tirzepatide costco for its efficacy in studies related to diabetes and weight management, backed by rigorous manufacturing standards.